Skip to main content

Esure achieves 10 times return on genAI investment

A hand touch abstract stream information. Big data, technology, AI brain, data transfer, data flow, generative AI, large language model, binary, coding background

Esure has seen a seven to 10 times return on its investment in generative artificial intelligence technology evidenced to its executive team and shareholders, according to chief data officer Chris Pearce.

Speaking exclusively to Insurance Post, Pearce shared the provider has met or exceeded its projections on the benefits of genAI in the business, and there have been

Only users who have a paid subscription or are part of a corporate subscription are able to print or copy content.

To access these options, along with all other subscription benefits, please contact info@postonline.co.uk or view our subscription options here: https://subscriptions.postonline.co.uk/subscribe

You are currently unable to copy this content. Please contact info@postonline.co.uk to find out more.

Sorry, our subscription options are not loading right now

Please try again later. Get in touch with our customer services team if this issue persists.

New to Insurance Post? View our subscription options

Acrisure blames AI for slashing 2250 jobs

Acrisure is cutting around 11% of its global workforce, after chief executive and co-founder Greg Williams told staff advances in artificial intelligence and technology are reshaping how the business operates and serves clients.

Tom Needs to leave Applied Systems

Applied Systems Europe CEO Tom Needs is leaving the tech provider at the end of June, with Dave Chapman being named managing director and leading the company moving forward.

Howden launches Web3 risk ecosystem

The broking group has expanded its crypto theft insurance product, bringing together specialist vendors across pre-emptive risk management and post-incident recovery.

Most read articles loading...

You need to sign in to use this feature. If you don’t have an Insurance Post account, please register for a trial.

Sign in
You are currently on corporate access.

To use this feature you will need an individual account. If you have one already please sign in.

Sign in.

Alternatively you can request an individual account here